Physician
Pathology Associates of Southern California
Pathology Associates of Southern California was paid $4.39M by Medicaid between Jan 2018 and Dec 2024, across 168 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 12% of everything it billed.
33Billing provider infoPATHOLOGY ASSOCIATES OF SOUTHERN CALIFORNIA
BURBANK, CA 91505
BURBANK, CA 91505
33aNPI1912991597assigned 09/09/2005
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$4.39M
24GClaims1,847,081
24DCodes billed168
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#10 of 222
Median peer was paid$42K
This provider vs. median104×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 286,656 | $432K | |
| 2019 | 296,373 | $812K | |
| 2020 | 227,722 | $619K | |
| 2021 | 267,025 | $981K | |
| 2022 | 283,779 | $715K | |
| 2023 | 280,777 | $489K | |
| 2024incomplete | 204,749 | $344K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 12% | 20,465 | 19,494 | $532K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 259,543 | 178,299 | $450K |
| 80053 | Comprehensive metabolic panel | 6.9% | 216,881 | 148,814 | $303K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 6.2% | 3,836 | 3,657 | $272K |
| 88307 | 5.0% | 5,465 | 5,357 | $222K | |
| 83735 | 4.8% | 91,262 | 30,316 | $210K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.6% | 3,773 | 3,625 | $203K |
| 85027 | 3.6% | 74,015 | 38,621 | $157K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.3% | 9,904 | 8,283 | $145K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.0% | 6,158 | 5,839 | $132K |
| 84484 | 2.6% | 54,100 | 47,827 | $113K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.3% | 29,618 | 28,372 | $102K |
156 more codes
| 80048 | Basic metabolic panel (calcium, ionized) | 2.2% | 92,548 | $95K |
| 83690 | 2.1% | 66,972 | $92K | |
| 88304 | 1.8% | 5,635 | $79K | |
| 83605 | 1.7% | 29,552 | $77K | |
| 83880 | 1.6% | 17,478 | $71K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.3% | 26,057 | $59K |
| 88342 | 1.1% | 3,067 | $50K | |
| 85379 | 1.1% | 13,618 | $50K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 47,227 | $49K |
| 80061 | Lipid panel | 1.1% | 22,691 | $48K |
| 87040 | <1% | 23,605 | $43K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 8,326 | $40K |
| 81001 | <1% | 86,683 | $39K | |
| 87186 | <1% | 17,360 | $38K | |
| 85610 | <1% | 33,136 | $38K | |
| 84145 | <1% | 8,724 | $28K | |
| 84439 | <1% | 15,421 | $27K | |
| 84100 | <1% | 39,270 | $24K | |
| 85730 | <1% | 24,889 | $22K | |
| 86592 | <1% | 15,159 | $21K | |
| 82948 | <1% | 27,128 | $21K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,686 | $21K |
| 87581 | <1% | 3,513 | $19K | |
| 82805 | <1% | 5,262 | $19K | |
| 87486 | <1% | 3,353 | $19K | |
| 82728 | <1% | 4,620 | $18K | |
| 86901 | <1% | 44,704 | $17K | |
| 86900 | <1% | 42,069 | $16K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,370 | $16K |
| 81003 | <1% | 49,755 | $16K | |
| 84702 | <1% | 8,183 | $14K | |
| 81025 | <1% | 14,578 | $14K | |
| 86850 | <1% | 29,608 | $14K | |
| 86140 | <1% | 18,297 | $14K | |
| 86880 | <1% | 7,422 | $13K | |
| 88302 | <1% | 673 | $13K | |
| 87081 | <1% | 15,041 | $13K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,556 | $12K |
| 87077 | <1% | 10,670 | $12K | |
| 83615 | <1% | 5,155 | $11K | |
| 82803 | <1% | 4,472 | $10K | |
| 87340 | <1% | 7,865 | $10K | |
| 84480 | <1% | 4,054 | $10K | |
| 82550 | <1% | 6,701 | $9K | |
| 83540 | <1% | 5,460 | $9K | |
| 87070 | <1% | 7,720 | $9K | |
| 80202 | <1% | 4,739 | $9K | |
| 82607 | <1% | 3,317 | $8K | |
| 83550 | <1% | 3,545 | $8K | |
| 82330 | <1% | 4,315 | $8K | |
| 84703 | <1% | 9,054 | $7K | |
| 86803 | <1% | 2,803 | $6K | |
| 82247 | <1% | 9,632 | $6K | |
| 87205 | <1% | 9,450 | $6K | |
| 86920 | <1% | 2,576 | $6K | |
| 88112 | <1% | 439 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,174 | $6K |
| 85055 | <1% | 1,384 | $5K | |
| 87631 | <1% | 732 | $5K | |
| 80076 | <1% | 4,143 | $4K | |
| 86703 | <1% | 1,330 | $4K | |
| 85018 | <1% | 5,536 | $4K | |
| 82570 | <1% | 4,982 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 807 | $4K |
| 85652 | <1% | 7,960 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 804 | $4K |
| 88312 | <1% | 213 | $4K | |
| 84550 | <1% | 5,993 | $4K | |
| 87451 | <1% | 3,224 | $3K | |
| 84466 | <1% | 1,571 | $3K | |
| 86705 | <1% | 1,771 | $3K | |
| 82746 | <1% | 911 | $3K | |
| 86701 | <1% | 2,171 | $3K | |
| 86709 | <1% | 1,741 | $3K | |
| 84156 | <1% | 3,611 | $3K | |
| 87807 | <1% | 1,184 | $3K | |
| 82140 | <1% | 1,268 | $3K | |
| 88108 | <1% | 232 | $2K | |
| 82553 | <1% | 1,029 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 58 | $2K |
| 88341 | <1% | 110 | $2K | |
| 82150 | <1% | 1,124 | $2K | |
| 84153 | <1% | 577 | $2K | |
| 85014 | <1% | 3,057 | $2K | |
| 87899 | <1% | 895 | $2K | |
| 86762 | <1% | 712 | $2K | |
| 83970 | <1% | 139 | $2K | |
| 80306 | <1% | 894 | $1K | |
| 80074 | <1% | 250 | $1K | |
| 85384 | <1% | 1,156 | $1K | |
| 86141 | <1% | 810 | $1K | |
| 85060 | <1% | 105 | $1K | |
| 86677 | <1% | 424 | $1K | |
| 82248 | <1% | 2,045 | $1K | |
| 88300 | <1% | 292 | $968.96 | |
| 84165 | <1% | 357 | $869.41 | |
| 88311 | <1% | 590 | $839.52 | |
| 80305 | <1% | 590 | $833.95 | |
| 80143 | <1% | 463 | $806.82 | |
| 86308 | <1% | 1,189 | $782.71 | |
| 87075 | <1% | 599 | $716.17 | |
| 87149 | <1% | 53 | $709.74 | |
| 87210 | <1% | 877 | $653.94 | |
| 80179 | <1% | 383 | $652.01 | |
| 82043 | <1% | 595 | $595.02 | |
| 89051 | <1% | 230 | $588.49 | |
| 84134 | <1% | 332 | $566.13 | |
| 82565 | <1% | 408 | $565.61 | |
| 86923 | <1% | 287 | $562.20 | |
| 87653 | <1% | 139 | $548.25 | |
| 87015 | <1% | 482 | $521.66 | |
| 84300 | <1% | 585 | $512.28 | |
| 83874 | <1% | 174 | $442.71 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 124 | $435.43 |
| 84132 | <1% | 917 | $413.95 | |
| 87420 | <1% | 804 | $403.48 | |
| 87324 | <1% | 237 | $389.30 | |
| 82533 | <1% | 95 | $378.74 | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,789 | $362.02 |
| 87045 | <1% | 219 | $351.35 | |
| 82009 | <1% | 463 | $271.49 | |
| 87147 | <1% | 481 | $270.76 | |
| 85045 | <1% | 200 | $244.60 | |
| 87400 | <1% | 493 | $234.24 | |
| 87102 | <1% | 83 | $188.71 | |
| 80329 | <1% | 237 | $174.51 | |
| 87450 | <1% | 179 | $164.27 | |
| 82010 | <1% | 109 | $154.45 | |
| 80047 | <1% | 205 | $129.07 | |
| 87220 | <1% | 163 | $92.09 | |
| 87449 | <1% | 43 | $72.59 | |
| 81002 | <1% | 76 | $64.73 | |
| 84478 | <1% | 38 | $60.46 | |
| 87116 | <1% | 47 | $59.31 | |
| 85651 | <1% | 194 | $56.62 | |
| 86430 | <1% | 54 | $53.67 | |
| 82270 | <1% | 91 | $52.47 | |
| 80069 | <1% | 39 | $51.56 | |
| 83935 | <1% | 60 | $40.40 | |
| 85032 | <1% | 213 | $38.70 | |
| 82947 | <1% | 49 | $31.50 | |
| 84157 | <1% | 65 | $26.19 | |
| 84295 | <1% | 30 | $16.49 | |
| 87088 | <1% | 13 | $11.11 | |
| 83930 | <1% | 12 | $10.95 | |
| 82945 | <1% | 13 | $7.24 | |
| 71046 | Radiologic examination, chest; 2 views | 0% | 775 | $0.00 |
| 70450 | Computed tomography, head or brain; without contrast material | 0% | 27 | $0.00 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 0% | 98 | $0.00 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 103 | $0.00 |
| 84112 | 0% | 59 | $0.00 | |
| 93976 | 0% | 12 | $0.00 | |
| 76642 | 0% | 19 | $0.00 | |
| 80320 | 0% | 106 | $0.00 | |
| 76819 | Fetal biophysical profile; without non-stress testing | 0% | 34 | $0.00 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialESTEBAN, JOSE (MANAGING PARTNER)